US: +1 617 696-7335 | EU: +31 317 728 104|info@ionoptix.com

Stretch regulation of β2-Adrenoceptor signalling in cardiomyocytes requires caveolae (2025)

2026-05-15T17:57:45-05:00

Fu J, Mansfield C, Diakonov I, Judina A, Delahaye M, Bhogal N, Sanchez-Alonso JL, Kamp T, Gorelik J. Stretch regulation of β2-Adrenoceptor signalling in cardiomyocytes requires caveolae. Cardiovasc Res. 2025 Apr 29;121(3):440-453. doi: 10.1093/cvr/cvae265.

Stretch regulation of β2-Adrenoceptor signalling in cardiomyocytes requires caveolae (2025)2026-05-15T17:57:45-05:00

Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo (2025)

2026-05-15T18:00:08-05:00

Shuvaev VV, Tam YK, Lee BW, Myerson JW, Herbst A, Kiseleva RY, Glassman PM, Parhiz H, Alameh MG, Pardi N, Muramatsu H, Shuvaeva TI, Arguiri E, Marcos-Contreras OA, Hood ED, Brysgel TV, Nong J, Papp TE, Eaton DM, Riley R, Palanki R, Musunuru K, Brenner JS, Mitchell MJ, Ferrari VA, Mui BL, Semple SC, Weppler SA, Atluri P, Margulies KB, Weissman D, Muzykantov VR. Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo. Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2409266122. doi: 10.1073/pnas.2409266122.

Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo (2025)2026-05-15T18:00:08-05:00

A new approach to characterize cardiac sodium storage by combining fluorescence photometry and magnetic resonance imaging in small animal research (2024)

2026-05-15T18:57:27-05:00

Christa M, Dithmar F, Weinaus T, Kohlhaas M, Arias-Loza AP, Hofmann M, Elabyad IA, Gutjahr FT, Maack C, Bauer WR. A new approach to characterize cardiac sodium storage by combining fluorescence photometry and magnetic resonance imaging in small animal research. Sci Rep. 2024 Jan 29;14(1):2426. doi: 10.1038/s41598-024-52377-w.

A new approach to characterize cardiac sodium storage by combining fluorescence photometry and magnetic resonance imaging in small animal research (2024)2026-05-15T18:57:27-05:00

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)

2026-05-15T18:57:47-05:00

Desai D, Song T, Singh RR, Baby A, McNamara J, Green LC, Nabavizadeh P, Ericksen M, Bazrafshan S, Natesan S, Sadayappan S. MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids. Cells. 2024 Nov 19;13(22):1913. doi: 10.3390/cells13221913.

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)2026-05-15T18:57:47-05:00

EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy (2023)

2026-05-15T18:58:02-05:00

Algül S, Schuldt M, Manders E, Jansen V, Schlossarek S, de Goeij-de Haas R, Henneman AA, Piersma SR, Jimenez CR, Michels M, Carrier L, Helmes M, van der Velden J, Kuster DWD. EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy. Circ Res. 2023 Aug 18;133(5):387-399. doi: 10.1161/CIRCRESAHA.122.322133.

EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy (2023)2026-05-15T18:58:02-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)

2026-05-27T10:10:01-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Dinani R, Manders E, Helmes M, Wang L, Knollmann B, Kuster DWD, van der Velden J. J Vis Exp. 2023 May 26;(195). doi: 10.3791/65326.

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)2026-05-27T10:10:01-05:00

Characterization of heterozygous and homozygous mouse models with the most common hypertrophic cardiomyopathy mutation MYBPC3c.2373InsG in the Netherlands (2023)

2026-05-15T18:58:16-05:00

Hilderink S, Schuldt M, Goebel M, Jansen VJ, Manders E, Moorman S, Dorsch LM, van Steenbeek FG, van der Velden J, Kuster DWD. Characterization of heterozygous and homozygous mouse models with the most common hypertrophic cardiomyopathy mutation MYBPC3c.2373InsG in the Netherlands. J Mol Cell Cardiol. 2023 Dec;185:65-76. doi: 10.1016/j.yjmcc.2023.10.008.

Characterization of heterozygous and homozygous mouse models with the most common hypertrophic cardiomyopathy mutation MYBPC3c.2373InsG in the Netherlands (2023)2026-05-15T18:58:16-05:00

Modified Langendorff-free Cardiomyocyte Isolation

2025-08-18T18:04:20-05:00

This protocol describes the isolation of primary adult mouse cardiomyocytes using sequential calcium depletion, enzymatic digestion, and gradual calcium reintroduction. The approach is adapted from the method of Matthew Ackers-Johnson et al.

Modified Langendorff-free Cardiomyocyte Isolation2025-08-18T18:04:20-05:00
Go to Top